Although GNG4 has been reported to be hypermethylated and down-regulated in bladder cancer [54], breast cancer [55], and glioblastoma [56], other studies have shown that GNG4 expression was significantly up-regulated in lung carcinoma [57], and colorectal cancer [58]. The gene discussed is GNG4; the disease is urinary bladder carcinoma.